<?xml version="1.0" encoding="UTF-8"?>
<ref id="B209">
 <label>209.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maes</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Bosteels</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>De Leeuw</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Declercq</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Van Damme</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Delporte</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial</article-title>. 
  <source>Trials.</source> (
  <year>2020</year>) 
  <volume>21</volume>:
  <fpage>468</fpage>
  <pub-id pub-id-type="doi">10.1186/s13063-020-04453-5</pub-id>
  <pub-id pub-id-type="pmid">32493441</pub-id>
 </mixed-citation>
</ref>
